USPTO 2015–2025 USPTO PatentsView US Corporation

NEW York Society FOR THE Ruptured AND Crippled, Maintaining THE Hospital FOR Special Surgery

USPTO PatentsView assignee record - 19 granted patents across 20 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, NEW ranks #15,487 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 20 technology areas.

#15,487
of 49,997 US assignees by volume
Top 46%
by Innovation Score (36.7/100)
16.2
avg claims per patent
-54%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15487 · US Corporation #15,487 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 19 grants
  • MID-PACK #15,487/49,997
  • PHOTO-FINISH National University…
  • CPC-FOCUS A61F · 20 areas
  • INNOV-THIN 36.7/100
  • CLAIMS-RICH 16.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -54% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: National University Corporation Magaoka University OF Technology (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How NEW’s 36.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around NEW

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows NEW's Innovation Score is 36.7/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for NEW?

Each dot is one of NEW’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). NEW’s own 16.2 claims/patent is ABOVE the 14.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

NEW vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 18.918.91919.1 5101520 Granted patents (volume) Avg claims / patent National University Corporation Magaoka University OF Technology - 19, 11.37National Universi…Naval Group - 19, 11.11Naval GroupNeurogami Medical, Inc - 19, 18.37Neurogami MedicalNEW Revo Brand Group, LLC - 19, 15.21NEW Revo Brand Gr…Nisshinbo Micro Devices Inc. - 19, 8.79Nisshinbo Micro D…Nonin Medical, Inc. - 19, 16.58Nonin MedicalNTI Co., Ltd - 19, 14.95NTINtn-snr Roulements - 19, 14.79Ntn-snr RoulementsNEW York Society FOR THE Ruptured AND Crippled, Maintaining THE Hospital FOR Special Surgery - 19, 16.21NEW York Society…
NEW vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where NEW's grants concentrate

NEW York Society FOR THE Ruptured AND Crippled, Maintaining THE Hospital FOR Special Surgery is a focused PatentsView assignee: 20 CPC subclasses with 47.4% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2018. By volume, NEW sits between National University Corporation Magaoka University OF Technology and Ntn-snr Roulements.

NEW's three-year grant acceleration

NEW York Society FOR THE Ruptured AND Crippled, Maintaining THE Hospital FOR Special Surgery shows 1 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at NEW's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows NEW holds 19 patents at rank #15,483, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near NEW

By rank, the assignees closest to #15,483 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in NEW's primary technology class.

NEW's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 46% higher than 54% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20152016201720182019202020212024 1
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
NEW York Society FOR THE Ruptured AND Crippled, Maintaining THE Hospital FOR Special Surgery patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 15.8%
2016 3 15.8%
2017 3 15.8%
2018 1 5.3%
2019 3 15.8%
2020 3 15.8%
2021 2 10.5%
2024 1 5.3%

Which technologies does NEW York Society FOR THE Ruptured AND Crippled, Maintaining THE Hospital FOR Special Surgery patent most?

Top 15 of 20 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

NEW York Society FOR THE Ruptured AND Crippled, Maintaining THE Hospital FOR Special Surgery's patent record in context - here's where to go next.

  • NEW York Society FOR THE Ruptured AND Crippled, Maintaining THE Hospital FOR Special Surgery's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 47.4% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #15,487 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare NEW York Society FOR THE Ruptured AND Crippled, Maintaining THE Hospital FOR Special Surgery against National University Corporation Magaoka University OF Technology, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 36.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.